HDL-CHOLESTEROL Precipitant(BIOLABO HDL-CHOLESTEROL Precipitant)
- UID
- IMP/IVD/2023/000051_e0ce5233f280edefc24d1b68bccdd9df_4c9a1b5d33b3696cdd4bdb08e436eb9f
- Device class
- Class B
- Brand name
- BIOLABO ACID CALCIUM Arsenazo III Method
- License holder
- Wheecon Instruments Private Limited
- Approving authority
- CDSCO
- Product information
- The principal role of high density lipoproteins (BIOLABO ACID CALCIUM Arsenazo III Method) in lipid metabolism is the uptake and transport of cholesterol from peripherical tissues to the liver through a process known as reverse cholesterol transport. Low HDL cholesterol levels are strongly ssociated with an increased risk of coronary heart disease and coronary artery disease. Hence, the determination of serum HDL-Cholesterol is a useful tool in identifying high-risk patients. Increased Total Cholesterol/HDL-Cholesterol ratio is significant of an increased risk of atherosclerosis
HDL-CHOLESTEROL Precipitant(BIOLABO HDL-CHOLESTEROL Precipitant) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_e0ce5233f280edefc24d1b68bccdd9df_4c9a1b5d33b3696cdd4bdb08e436eb9f. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.